Beta-Alanine and Exercise Capacity: Who Does It Actually Work For?

Beta-alanine is a non-protein amino acid that, once absorbed, combines with histidine to form carnosine — a dipeptide stored mainly in skeletal muscle, where it acts as a chemical buffer neutralizing hydrogen ions produced during intense exercise. This exact mechanism is responsible for the characteristic, harmless skin tingling (paresthesia) felt by many users shortly after taking a higher dose — an effect distinct enough that some people treat it as proof the supplement "definitely works."

The problem is that a felt skin tingle and a real improvement in athletic performance are two entirely different physiological phenomena, not necessarily linked in any simple way. The largest meta-analysis on this topic to date was the first to separate two different kinds of effect in its analysis — general "exercise capacity" and a narrower, more practical "performance" — and this distinction changes how you should understand what this supplement actually does.

The starting point is the 2017 work by Saunders and colleagues, published in the British Journal of Sports Medicine — the broadest meta-analysis on this topic to date, covering dozens of studies and, importantly, explicitly separating the effect on capacity from the effect on performance itself.

The earlier 2012 meta-analysis by Hobson and colleagues, published in Amino Acids, provides additional context on the scale of the effect and typical cumulative dosing used in studies.

The hydrogen-ion buffering mechanism suggests beta-alanine should work strongest in high-intensity exercise lasting roughly one to four minutes, where acidosis in the muscle is the main limiting factor and anaerobic metabolism plays a dominant role. This time range best matches the results of Saunders' meta-analysis, where the effect on capacity was largest.

It's also worth emphasizing that very short efforts (under 60 seconds, e.g., a single sprint) or very long ones (over a dozen or so minutes, dominated by aerobic metabolism) derive considerably less benefit from this mechanism than efforts in the mid-range time span, where muscle acidosis is the main limiting factor.

In practice, this means beta-alanine makes sense mainly as part of a longer-term supplementation strategy for high-intensity, mid-duration disciplines, not as a one-off "boost" before a single workout — and it's worth judging its effectiveness by actual results over time, not by the felt tingling.

Beta-alanine is among the better-studied ergogenic supplements, but its reputation as a "sure thing" partly stems from an easily felt side effect, not from the strength of evidence for improved real sport performance. Separating "capacity" from "performance" in Saunders' meta-analysis is exactly the kind of nuance worth knowing before deciding on supplementation.

For people training high-intensity disciplines lasting on the order of minutes, regular, multi-week supplementation has solid evidentiary support. For people counting on a direct, measurable translation into race completion time or competition results, it's worth managing expectations — the available data doesn't confirm this effect equally strongly.